AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
Astrazeneca CFO Talks Growth
Bloomberg Talks
AstraZeneca's Bold Revenue Growth Plans and Strategic Investments
Exploring AstraZeneca's strategic plans for achieving 7% to 8% top-line growth through a diverse portfolio focused on oncology, rare diseases, metabolic disorders, and respiratory issues, including the launch of 20 new medicines and investments in cutting-edge technologies like cell therapy and antibody drug conjugates.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode